4.6 Article

Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Prognostic value of PCSK9 levels in patients with acute coronary syndromes

Baris Gencer et al.

EUROPEAN HEART JOURNAL (2016)

Article Medicine, General & Internal

Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes

Federico Carbone et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Medicine, General & Internal

Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke

Federico Carbone et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Medicine, General & Internal

Leptin/adiponectin ratio predicts poststroke neurological outcome

Federico Carbone et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Peripheral Vascular Disease

PCSK9: A key factor modulating atherosclerosis

Sha Li et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)

Article Medicine, General & Internal

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Jennifer G. Robinson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

Marc S. Sabatine et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

The Influence of OLR1 and PCSK9 Gene Polymorphisms on Ischemic Stroke: Evidence from a Meta-Analysis

Anthony Au et al.

SCIENTIFIC REPORTS (2015)

Review Neurosciences

Rational modulation of the innate immune system for neuroprotection in ischemic stroke

Diana Amantea et al.

FRONTIERS IN NEUROSCIENCE (2015)

Review Hematology

Low-Density Lipoprotein Receptor-Related Protein-1 Role in the Regulation of Vascular Integrity

Dudley K. Strickland et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)

Article Biochemistry & Molecular Biology

Understanding the Multifaceted Role of Inflammatory Mediators in Ischemic Stroke

D. Amantea et al.

CURRENT MEDICINAL CHEMISTRY (2014)

Article Endocrinology & Metabolism

Plasma PCSK9 Is a Late Biomarker of Severity in Patients With Severe Trauma Injury

Maelle Le Bras et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Biochemistry & Molecular Biology

PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke

Estelle Rousselet et al.

JOURNAL OF LIPID RESEARCH (2011)

Article Clinical Neurology

Sex differences in the prognostic value of the lipid profile after the first ischemic stroke

E. Cuadrado-Godia et al.

JOURNAL OF NEUROLOGY (2009)

Article Clinical Neurology

Serum Cholesterol LDL and 90-Day Mortality in Patients With Intracerebral Hemorrhage

Jose Maria Ramirez-Moreno et al.

STROKE (2009)

Article Genetics & Heredity

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

Cristen J. Willer et al.

NATURE GENETICS (2008)